Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Biopreservation and Biobanking
|
May 22, 2014
How much will the biobanking industry come to rely on private companies?
Brian J Clark, John M Baust, Glyn Stacey
Nature Protocols
|
May 1, 2010
Detection of Mycoplasma in cell cultures
Lesley Young, Julia Sung, Glyn Stacey, et al.
Stem Cell Reviews and Reports
|
November 1, 2011
Global solutions to the challenges of setting up and managing a stem cell laboratory
Maneesha S Inamdar, Lyn Healy, Abhishek Sinha, et al.
Cell Proliferation
|
March 11, 2022
Developing standards to support cell technology applications
Jiani Cao, Glyn Stacey, Ng Shyh-Chang, et al.
Stem Cells Translational Medicine
|
July 14, 2016
First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine
Kunie Sakurai, Andreas Kurtz, Glyn Stacey, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 18, 2012
Standardization of pluripotent stem cell cultures for toxicity testing
Francesca Pistollato, Susanne Bremer-Hoffmann, Lyn Healy, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
May 5, 2019
A strategic road map to filing a Biologics License Application for a pluripotent stem cell derived therapeutic product
Abla A Creasey, Glyn Stacey, Kapil Bharti, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 11, 2017
Scientific considerations for the regulatory evaluation of cell therapy products
John Petricciani, Takao Hayakawa, Glyn Stacey, et al.
Current Stem Cell Reports
|
July 31, 2015
Setting Up a Haplobank: Issues and Solutions
Jacqueline Barry, Johan Hyllner, Glyn Stacey, et al.
Stem Cells and Development
|
December 3, 2014
Regulatory insight into the European human pluripotent stem cell registry
Andreas Kurtz, Glyn Stacey, Luam Kidane, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Biopreservation and Biobanking
|
May 22, 2014
How much will the biobanking industry come to rely on private companies?
Brian J Clark, John M Baust, Glyn Stacey
Nature Protocols
|
May 1, 2010
Detection of Mycoplasma in cell cultures
Lesley Young, Julia Sung, Glyn Stacey, et al.
Stem Cell Reviews and Reports
|
November 1, 2011
Global solutions to the challenges of setting up and managing a stem cell laboratory
Maneesha S Inamdar, Lyn Healy, Abhishek Sinha, et al.
Cell Proliferation
|
March 11, 2022
Developing standards to support cell technology applications
Jiani Cao, Glyn Stacey, Ng Shyh-Chang, et al.
Stem Cells Translational Medicine
|
July 14, 2016
First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine
Kunie Sakurai, Andreas Kurtz, Glyn Stacey, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 18, 2012
Standardization of pluripotent stem cell cultures for toxicity testing
Francesca Pistollato, Susanne Bremer-Hoffmann, Lyn Healy, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
May 5, 2019
A strategic road map to filing a Biologics License Application for a pluripotent stem cell derived therapeutic product
Abla A Creasey, Glyn Stacey, Kapil Bharti, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 11, 2017
Scientific considerations for the regulatory evaluation of cell therapy products
John Petricciani, Takao Hayakawa, Glyn Stacey, et al.
Current Stem Cell Reports
|
July 31, 2015
Setting Up a Haplobank: Issues and Solutions
Jacqueline Barry, Johan Hyllner, Glyn Stacey, et al.
Stem Cells and Development
|
December 3, 2014
Regulatory insight into the European human pluripotent stem cell registry
Andreas Kurtz, Glyn Stacey, Luam Kidane, et al.
Page
of 6